IHE News

Join the IHE in Impacting Biosimilars Policy at CADTH 2017 - Participate in the IHE Life Sciences Open Innovation Platform

The Institute of Health Economics is gathering input for an IHE Forum on biosimilar policy that will be held at the CADTH 2017 meeting in April. To obtain stakeholder perspectives in this important policy area, the IHE is launching an online “ideasourcing” platform, called the IHE Life Sciences Open Innovation Platform™ to encourage a broad pan-Canadian community to comment on key issues and topics related to biosimilar policy.

Participation is easy. Once you register, you can add your ideas on biosimilar policy in key areas highlighted on the platform, comment and contribute to the ideas of others, and vote for the ones that have the most promise. Your level of participation is up to you, and you don't have to be an expert to contribute.

Preliminary campaigns include:

  • Biosimilar Policy Stakeholder Engagement
  • Biosimilar Evidence Generation
  • Biosimilar Education & Experience
  • Enabling Biologics Infrastructure
  • Active & Sustained Biologics Competition

Ideas from the platform with the most support will be presented to policy leaders at an IHE Biosimilars meeting, at the 2017 CADTH Symposium. Deadline to contribute for this particular initiative is April 1st, however, you will want to contribute early and check back often, so that your ideas and those of others can be further developed, supported, and refined by the community.

The platform and the above mentioned campaign areas were developed in response to the 2016 IHE Biosimilars Forum and IHE Biosimilars Forum Summary Report. For more information on the IHE Biosimilars Forum, please visit the following webpage: http://www.ihe.ca/research-programs/knowledge-transfer-dissemination/roundtables/ihebf/about-ihebf.

IHE Life Sciences Open Innovation Platform Registration:

To participate in the IHE Life Sciences Open Innovation Platform, please register at:  https://iheinnovation.ideascale.com/a/register

For more information on the platform and how to get involved, please email [email protected].